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Complex segregation analysis (CSA) is a general method
for evaluating the transmission of a trait within pedi-
grees. It proceeds by testing models of varying degrees
of generality, both to determine whether a Mendelian
locus is likely to exert a large effect on the phenotype
of interest and to estimate the magnitude of genetic
sources of variation in the trait. This information is val-
uable both as a prelude to linkage analysis, which gen-
erally assumes Mendelian transmission, and in providing
a model on which to base parametric linkage methods.
CSA is distinguished from (simple) segregation analysis,
in that the latter evaluates whether the proportion of
affected and unaffected offspring in families is consistent
with Mendelian expectations. In contrast, CSA can be
applied to any pedigree structure and works with both
qualitative and quantitative traits. In the past, complex
pedigrees might have been broken into their constituent
nuclear families, and quantitative traits would have been
dichotomized, but CSA obviates the need for either of
these steps, either of which can lead to an unacceptable
loss of transmission information. Additionally, CSA can
consider more complicated patterns of transmission and
environmental perturbations.
Simulation studies have consistently found CSA to be
both reliable and robust. The individual contributions
and summary papers for past Genetic Analysis Work-
shops suggest that the model underlying simulated data
can be reasonably recovered by a variety of standard
CSA methods, despite unmodeled effects that might be
expected in a complex disorder (Blangero 1995). In ad-
dition, a simulation study (Hodge 1995) showed that
genetic effects in a data set simulated for an oligogenic
trait could neither be determined by CSA nor mapped
by linkage, indicating that, like positive evidence for a
Mendelian locus, negative results from CSA may be of
great utility. In practice, there is usually considerably less
information in the analysis of real diseases than would
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be available in simulation studies, but, judged on the
basis of its record, CSA is clearly a powerful tool in the
elucidation of the genetic basis of both qualitative and
quantitative traits.
Application of CSA
I will describe the CSA methods with record brevity,
facilitated by the absence of any equations; more-de-
tailed descriptions should be sought elsewhere (Pairitz
et al. 1988; Khoury et al. 1993). In CSA, a variety of
models are considered. Parameters commonly estimated
by CSA include the transmission probabilities; the allele
frequencies; either the genotype means, for quantitative
traits, or the penetrances for each genotype, for quali-
tative traits; the variance within genotypes; and any re-
sidual genetic correlations not explained by the Men-
delian locus. A general model will often contain the most
parameters. This model is then compared with a Men-
delian transmission model, an environmental transmis-
sion model, and a polygenic model. Under a Mendelian
model, the transmission probabilities—that is, the prob-
abilities that the AA, Aa, and aa genotypes will pass on
an A allele—do not significantly differ from the Men-
delian expectations of 1, .5, and 0, respectively, whereas
in the general model these transmission probabilities can
take any value. Under the environmental model, these
probabilities are all equal—the phenotypic mode that a
child is in is unrelated to the mode that the parent is in.
Both the Mendelian and environmental models can con-
tain multiple small genetic and environmental effects;
however, these are the only effects in a polygenic model,
which has no large deviation in the trait caused by either
a major locus or the environment. Should a Mendelian
model be favored in a data set, dominant and recessive
Mendelian submodels can then be evaluated.
Important complicating factors include the assump-
tion of a normal distribution of a quantitative trait, in-
corporation of adjustments both for covariates and for
possible covariate interactions, and the adjustment for
the ascertainment scheme. Although a simple application
of CSA is to investigate the possible effects of a single
two-allele locus with or without residual genetic corre-
lations, CSA methods can also be extended to incor-
porate more-complex modes of inheritance. Finally, the
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choice of the phenotype to be modeled is not always
simple, particularly for a disease. Consistent, rational
diagnostic criteria are required.
Models are generally compared by a likelihood ratio
test. The likelihood of each model, which is proportional
to the probability of the data, given the model and the
family structure, is approximated or computed. If one
model is a submodel of the other, then the likelihoods
of the two models can be compared to test whether the
fit of the restricted model is significantly worse than that
of the unrestricted model, in which more parameters are
estimated. Although CSA is generally done by approx-
imation methods as implemented by the computer pack-
ages PAP (Hasstedt and Cartwright 1981; Hasstedt
1993) and SAGE (1994), newer Monte Carlo–Markov
chain methods, such as that implemented in the MOR-
GAN program (Thompson 1994), provide estimates
from the true likelihood surface.
Uses of CSA
To date, LOD-method linkage analysis (i.e., “model
based” linkage analysis, as described by Elston [1998],
in this issue of the Journal) has been the most successful
method in the mapping of disease loci. This method
depends on specification of a reasonable approximation
of the mode of inheritance. This approximation can be
derived from the parameters estimated by CSA in ap-
propriate samples. Although power may be affected,
two-point LOD-method linkage analysis is reasonably
robust to model misspecification, as long as the mode
of inheritance is correct. Misspecification may include
over- or underestimation of the disease-allele frequency,
variation from the true age-dependent penetrance func-
tion, or errors in the phenocopy rate. Indeed, misspecifi-
cation may even include the failure to model the presence
of a second, epistatic genetic locus (Vieland et al. 1992).
Model misspecification tends to result in the overesti-
mation of the recombination fraction between the dis-
ease locus and the marker. Since parametric multipoint
linkage methods measure the recombination fractions
from several markers, they do not allow such overesti-
mation, and they are therefore less robust to model mis-
specification (Risch and Giuffra 1992).
The existence of a Mendelian trait is an underlying
assumption of linkage analyses used to map trait loci.
An interesting proposal for proceeding with linkage
analysis even in the absence of an accurate model of
transmission comes in a pair of recent papers. Hodge et
al. (1997) show that, because of the robustness of two-
point LOD-method linkage analysis to model misspecifi-
cation, arbitrary dominant and recessive models may
often be applied to the transmission of a qualitative trait.
This approach, which can lead to a variable loss of sta-
tistical power (Greenberg et al. 1998), assumes the pres-
ence of one or more genetic loci underlying the trait,
and the criteria for the assessment of linkage may need
to be modified when the probability of an underlying
major locus is unknown. Should there be evidence of
Mendelian transmission, however, the approach advo-
cated by Greenberg et al. may be very useful when mul-
tiple loci contribute to a qualitative trait and when the
model estimated by CSA does not match the transmis-
sion of some locus of interest. However, such an appli-
cation does not obviate the need for CSA in general.
CSA can support, although it cannot prove, the Men-
delian segregation of a trait. If Mendelian segregation is
not supported, analyses of candidate loci or random
markers for linkage to the trait of interest would likely
be unproductive, at least in the same data set. However,
because CSA can both falsely reject and falsely support
a Mendelian locus, it would be prudent to require con-
sistent evidence of a Mendelian locus from several dif-
ferent CSA studies before linkage studies are undertaken.
CSA can also be used to further define the genetic
features of a trait. It can be used to evaluate etiologic
heterogeneity in a trait, either by doing CSA in defined
subsets or by contrasting the likelihoods under compet-
ing models for each family. It should be noted that there
are clinical applications of transmission information
from CSA that are not addressed here. CSA can be used
either to look for residual genetic effects after adjustment
for known genetic loci or to evaluate the independence
of two traits (Pairitz et al. 1988). Probable genotypes
can be assigned to pedigree members, and the effects of
these genotypes on other traits can then be estimated
(Jarvik et al. 1994).
Limitations of CSA
The major limitation of CSA is that a large amount
of a very specific type of data is generally needed. As-
certainment of an appropriate sample is also necessary.
The most appropriate samples are either population
based, in which case no ascertainment correction is
needed, or they are selected through a phenotype-based
ascertainment scheme, for which ascertainment correc-
tions can be implemented. Adjustment for ascertainment
in CSA still needs development (Wijsman and Amos
1997). For instance, there are no appropriate methods
to adjust for the type of ascertainment that is generally
used to collect families for linkage analysis of rarer traits.
Because linkage analysis generally relies on the collection
of a highly selected group of densely affected families,
and because these families are rare, the model estimates
for use in LOD-method linkage analysis often must be
drawn from CSA on samples other than the sample of
densely affected families collected for linkage analysis.
The amount of necessary data is expected to be pro-
portionate to the number of parameters estimated, lim-
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iting the ability to evaluate more-complex models. Ad-
ditionally, there is no reliable method to determine the
sample size required for a desired level of power to detect
a Mendelian locus by CSA. Sample sizes generally range
in the mid hundreds of individuals, for quantitative
traits, and can be in the thousands, for rare, dichoto-
mous traits. Larger-sized families are expected to reduce
the needed sample size, as a result of the increase in
transmission information. Fortunately, experience sug-
gests that nonpaternity, at least when it occurs at an
average frequency, has little effect on the model chosen
under CSA, so genetic testing is usually not necessary.
Another practical limitation is the inability to distin-
guish between the effect of a single locus that underlies
a trait and the effects of two or more independently
acting loci with similar transmission patterns. For ex-
ample, all dominant hereditary prostate cancer loci
would be detected as if they were a single locus with a
disease-allele frequency equaling that of the sum of sev-
eral disease alleles. The resulting overestimate of allele
frequency would result both in an overestimate of the
statistical power to detect a locus, as well as in model
misspecification that could reduce the power to detect
each contributing locus, using linkage analysis.
Analytic limitations such as the issues of local maxima
for the parameter maximum-likelihood estimates, the es-
timation of parameters whose expected values are on
the 0 and 1 boundaries, and convergence problems are
not considered here. Analytic methods for CSA continue
to improve (Snow and Wijsman 1998), but programs
for doing CSA remain unwieldy.
Potential Errors
In the implementation of CSA, one common error that
can lead to a false conclusion of Mendelian segregation
is the failure to adjust adequately for the nonrandom
ascertainment of pedigrees. Should pedigrees be selected
for multiple affected individuals, the disorder may ap-
pear to have a Mendelian pattern of inheritance.
Failure to test whether the transmission probabilities
are Mendelian—that is, failure to contrast the general
and the Mendelian model—can also lead to the false
conclusion that a Mendelian locus exists, particularly in
the case of skewed data (Demenais and Bonney 1989).
An entertaining paper reporting that misapplied CSA
might conclude that there is an autosomal recessive gene
for medical-school attendance did, in fact, find that the
fit of the Mendelian model was significantly worse than
that of the general model (McGuffin and Huckle 1990);
in other words, the Mendelian transmission probabilities
could be rejected, and one could not conclude that there
is a Mendelian locus for medical-school attendance. Ex-
amination of the transmission probabilities is now rou-
tinely done, but it may have been neglected in older
papers in the literature.
Practical Examples of CSA
Traits for which CSA results have contributed to the
identification of genes include breast cancer and prostate
cancer. CSAs have supported an infrequent autosomal
dominant breast cancer locus (Williams and Anderson
1984; Newman et al. 1988). Newman et al. estimated
that the breast cancer–susceptibility allele has a fre-
quency of .0006 and that carriers have an 82% lifetime
risk of breast cancer whereas noncarriers have an 8%
lifetime risk. The strength of this result supported at-
tempts to map such a gene and provided parameter es-
timates for the linkage analyses. These efforts were suc-
cessful, resulting in the mapping and subsequent cloning
of the autosomal dominant breast cancer–susceptibility
loci, BRCA1 (Hall et al. 1990) and BRCA2 (Wooster et
al. 1994). The existence of more than one locus should
not be surprising, given the preceding discussion of CSA
limitations.
A similar story has emerged for prostate cancer. CSAs
by several groups support an autosomal dominant pros-
tate cancer–susceptibility locus. The early report by Car-
ter et al. (1992) suggested that an autosomal dominant
prostate cancer–susceptibility allele occurs with a fre-
quency of .003 and confers an age-dependent risk max-
imizing at a penetrance of 88% by age 85 years in males.
By means of models based at least in part on the au-
tosomal dominant CSA results of Carter et al., two au-
tosomal dominant prostate cancer–susceptibility loci
have been mapped: HPC-1 (Smith et al. 1996) and PCaP
(Berthon et al. 1998). As was the case for breast cancer,
CSA did not distinguish the presence of more than one
dominant locus for prostate cancer. Indeed, the two loci
described do not appear to be segregating in many high-
risk prostate cancer families, suggesting that additional
loci are yet to be found (McIndoe et al. 1997; Berthon
et al. 1998; Eeles et al. 1998). CSA can be used as a
tool to investigate disease heterogeneity when the in-
heritance pattern may differ in subsets of a sample. Moll
et al. (1989) exploited this in their investigation of the
transmission of apolipoprotein A1. By contrasting the
likelihoods of the data for each family, under alternative
models, Moll et al. were able to estimate the fraction of
families segregating a Mendelian locus. Similarly, by
comparing individual family likelihoods for alternative
models, Jarvik et al. (1994) concluded that the trans-
mission of apolipoprotein B level is genetically hetero-
geneous.
In the case of a complex disease for which subsets can
be defined, CSA can be performed on the subsets, and
the final models can be compared by a heterogeneity
test. An example of such an analysis is the division of
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families with Alzheimer disease, according to whether
they do or do not have an apolipoprotein E, e4 allele.
When models for each subset were contrasted, it was
concluded that the e4 group and the non-e4 group had
different patterns of transmission of Alzheimer disease
(Jarvik et al. 1996), supporting a role for this allele in
Alzheimer disease.
Using the probability of each genotype for each in-
dividual, one can also assign putative genotypes for a
Mendelian locus detected by CSA. For an apolipoprotein
B–elevating locus detected by CSA, assigned genotypes
have been shown to predict the presence of familial com-
bined hyperlipidemia but not of hyperapobetalipopro-
teinemia. The results support both the separate etiology
of these two overlapping disorders and the role of the
putative apolipoprotein B–elevating locus in the former
(Jarvik et al. 1993, 1994).
Conclusions
To quote Elston and Stewart (1971, p. 523), “the pur-
pose of analysing pedigree data is to establish the pres-
ence or absence of a genetic mechanism for the mani-
festation of a particular trait of set of traits; to elucidate
such a mechanism, if it is present; and to classify indi-
viduals for their genotypes.” A disease with complex
inheritance, one that is not transmitted in a simple Men-
delian fashion, often occurs through the action of mul-
tiple Mendelian loci, polygenic loci, and environmental
components. As simply inherited traits are elucidated
and mapped, we are left to the job of understanding the
complex traits, which are generally of more significance
in human disease. When applied to such a complex dis-
ease or trait, CSA allows us to further the goals stated
by Elston and Stewart.
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